Search Within

Sergio Andres Giralt

  1. "2023"
Formats
  1. Meeting Abstract (68)
  2. Journal Article (30)
  3. Research Letter (3)
  4. Review (3)
Groups
  1. Bone Marrow Transplant (104)
  2. Center for Hematologic Malignancies (104)
  3. Department of Medicine (104)
  4. Hematologic Malignancies, Division of (104)
  5. Survivorship Research (75)
  6. CTCR Scholars (66)

More Groups

People
  1. Gunjan Shah (55)
  2. Michael Scordo (53)
  3. Heather Landau (40)
  4. David Chung (37)
  5. Miguel-Angel Perales (35)
  6. Oscar Lahoud (35)

More People

Years
  1. 2023 (104)
Publications
  1. Blood (37)
  2. Clinical Lymphoma, Myeloma and Leukemia (19)
  3. Bone Marrow Transplantation (11)
  4. Blood Advances (6)
  5. American Journal of Hematology (4)
  6. Journal of Clinical Oncology (4)

More Publications

Publishers
  1. American Society of Hematology (43)
  2. Elsevier Inc. (22)
  3. Nature Publishing Group (14)
  4. American Society of Clinical Oncology (4)
  5. John Wiley & Sons, Inc. (4)
  6. S. Karger AG (2)

More Publishers

Results (104)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Treatment outcomes and prognostic factors with lenalidomide, bortezomib, and dexamethasone (RVd) alone versus RVd plus autologous stem cell transplantation (ASCT) in African American (AA) patients (pts) with newly diagnosed multiple myeloma (NDMM) in the DETERMINATION phase 3 trial
    Meeting Abstract

    Houde, C. A.; Khan, A.; Jacobus, S. J.; Hassoun, H.; Anderson, L. D. Jr; Merz, L. E.; Zon, R. L.; Efebera, Y.; Buck, T.; Innis-Shelton, R. D.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Idecabtagene vicleucel (ide-cel) versus standard (std) regimens in patients (pts) with triple-class-exposed (TCE) relapsed and refractory multiple myeloma (RRMM): Analysis of cytopenias and infections in pts from KarMMa-3
    Meeting Abstract

    Baz, R.; Otero, P. R.; Ailawadhi, S.; Arnulf, B.; Patel, K. K.; Nooka, A. K.; Costa, L.; Raje, N. S.; Abrahamsen, I. W.; Delforge, M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • High-dose targeted radiation with (131)I-apamistamab prior to HCT demonstrated a dose-response for durable complete remission in patients with R/R AML
    Meeting Abstract

    Litzow, M. R.; Chen, G.; Gyurkocza, B.; Nath, R.; Seropian, S.; Choe, H.; Abboud, C. N.; Koshy, N.; Tomlinson, B. K.; Abhyankar, S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Patterns and safety of glucocorticosteroids use following CD19 CAR-T cell therapy for B-cell lymphoma
    Meeting Abstract

    Luttwak, E.; Flynn, J. R.; Devlin, S. M.; Cassanello, G.; Corona, M.; Dahi, P. B.; Luna De Abia, A.; Fein, J.; Giralt, S. A.; Landego, I.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Comparison of bendamustine versus fludarabine/cyclophosphamide lymphodepletion in adult patients receiving CD19 CAR-T cell therapy
    Meeting Abstract

    Landego, I.; Nemirovsky, D.; Devlin, S. M.; Wills, B.; Parascondola, A.; Saldia, A.; Dahi, P. B.; Tomas, A. A.; Ip, A.; Suh, H. C.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • First fever between lymphodepletion and day 30 after CAR-T cell therapy: Patterns, origins, and implications in lymphoma patients
    Meeting Abstract

    Melica, G.; Luna, A.; Fei, T.; Corona, M.; Dahi, P. B.; Fein, J.; Giralt, S. A.; Raj, S.; Landego, I.; Lin, R. J.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • The impact of cardiovascular vulnerabilities in non Hodgkin lymphoma patients treated with chimeric antigen receptor T cell therapy
    Meeting Abstract

    Landego, I.; Flynn, J. R.; Goldman, A.; Devlin, S. M.; Luttwak, E.; Luna De Abia, A.; Corona, M.; Kedmi, M.; Sdayoor, I.; Fried, S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Use of a tissue-targeting recombinant human interleukin-22 fusion molecule (F-652) for the treatment of advanced refractory lower GI acute GVHD
    Meeting Abstract

    Satta, T.; Papadopoulos, E. B.; Gyurkocza, B.; Susman, P.; Singh, A.; Calafiore, M.; Giralt, S. A.; Perales, M. A.; Chen, J.; Li, S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • From widespread to tailored antifungal prophylaxis in lymphoma patients treated with CD19 CAR T- cell therapy: Less is better
    Meeting Abstract

    Melica, G.; Luna De Abia, A.; Corona, M.; Fein, J.; Dahi, P. B.; Giralt, S. A.; Landego, I.; Lin, R. J.; Palomba, M. L.; Parascondola, A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Long term follow-up after treatment with allogeneic off-the-shelf CAR T cell therapy for relapsed or refractory B-cell malignancies
    Meeting Abstract

    Shahid, S.; Flynn, G. C.; Mauguen, A.; Bieler, J.; Prockop, S. E.; Scaradavou, A.; Boelens, J. J.; Sauter, C. S.; Perales, M. A.; Giralt, S. A.; more...
    Blood (2023)

    Fulltext@MSK | Save